clintex.io
Open in
urlscan Pro
2606:4700:3033::6815:147f
Public Scan
Submitted URL: http://clintex.io/
Effective URL: https://clintex.io/
Submission: On September 20 via api from US — Scanned from DE
Effective URL: https://clintex.io/
Submission: On September 20 via api from US — Scanned from DE
Form analysis 2 forms found in the DOM
POST /#wpcf7-f1458-p1462-o1
<form action="/#wpcf7-f1458-p1462-o1" method="post" class="wpcf7-form init" novalidate="novalidate" data-status="init">
<div style="display: none;">
<input type="hidden" name="_wpcf7" value="1458">
<input type="hidden" name="_wpcf7_version" value="5.4.2">
<input type="hidden" name="_wpcf7_locale" value="en">
<input type="hidden" name="_wpcf7_unit_tag" value="wpcf7-f1458-p1462-o1">
<input type="hidden" name="_wpcf7_container_post" value="1462">
<input type="hidden" name="_wpcf7_posted_data_hash" value="">
</div>
<p><label><br>
<span class="wpcf7-form-control-wrap your-name"><input type="text" name="your-name" value="" size="40" class="wpcf7-form-control wpcf7-text wpcf7-validates-as-required" aria-required="true" aria-invalid="false" placeholder="Your name"></span>
</label></p>
<p><label><br>
<span class="wpcf7-form-control-wrap your-email"><input type="email" name="your-email" value="" size="40" class="wpcf7-form-control wpcf7-text wpcf7-email wpcf7-validates-as-required wpcf7-validates-as-email" aria-required="true"
aria-invalid="false" placeholder="Your email"></span> </label></p>
<p><label><br>
<span class="wpcf7-form-control-wrap your-message"><textarea name="your-message" cols="40" rows="10" class="wpcf7-form-control wpcf7-textarea wpcf7-validates-as-required" aria-required="true" aria-invalid="false"
placeholder="Your message"></textarea></span> </label></p>
<p><input type="submit" value="Submit" class="wpcf7-form-control wpcf7-submit"><span class="ajax-loader"></span></p>
<div class="wpcf7-response-output" aria-hidden="true"></div>
</form>POST /#wpcf7-f2026-p1462-o2
<form action="/#wpcf7-f2026-p1462-o2" method="post" class="wpcf7-form init" novalidate="novalidate" data-status="init">
<div style="display: none;">
<input type="hidden" name="_wpcf7" value="2026">
<input type="hidden" name="_wpcf7_version" value="5.4.2">
<input type="hidden" name="_wpcf7_locale" value="en">
<input type="hidden" name="_wpcf7_unit_tag" value="wpcf7-f2026-p1462-o2">
<input type="hidden" name="_wpcf7_container_post" value="1462">
<input type="hidden" name="_wpcf7_posted_data_hash" value="">
</div>
<p><label><br>
<span class="wpcf7-form-control-wrap your-email"><input type="email" name="your-email" value="" size="40" class="wpcf7-form-control wpcf7-text wpcf7-email wpcf7-validates-as-required wpcf7-validates-as-email" aria-required="true"
aria-invalid="false" placeholder="Your email"></span> </label></p>
<p><input type="submit" value="Submit" class="wpcf7-form-control wpcf7-submit"><span class="ajax-loader"></span></p>
<div class="wpcf7-response-output" aria-hidden="true"></div>
</form>Text Content
* About * CTi * Apps * Team * Partners * Roadmap * Contact * FAQ * CTi Token * Insights * Follow Us * REDDIT * MEDIUM * TELEGRAM * YOUTUBE * LINKEDIN * TWITTER * Powered by Google Übersetzer * -------------------------------------------------------------------------------- NEW MEDICINE: FASTER, SAFER, SMARTER. CTi TOKEN * -------------------------------------------------------------------------------- NEW MEDICINE: FASTER, SAFER, SMARTER. CTi TOKEN * -------------------------------------------------------------------------------- NEW MEDICINE: FASTER, SAFER, SMARTER. CTi TOKEN * -------------------------------------------------------------------------------- NEW MEDICINE: FASTER, SAFER, SMARTER. CTi TOKEN 1. 1 2. 2 3. 3 4. 4 * Previous * Next CURRENTLY, EFFICIENCY ISSUES IN CLINICAL TRIALS ARE COSTING BETWEEN $600,000 – $8M DOLLARS PER DAY, AND ARE SIGNIFICANTLY DELAYING THE DELIVERY OF NEW MEDICINE TO PATIENTS IN NEED. WE WANT TO CHANGE THAT. CLINTEX ARE A SOLUTION PROVIDER TO THE PHARMACEUTICAL INDUSTRY, AND THE TEAM BEHIND CTI – CLINICAL TRIALS INTELLIGENCE: A new type of software platform aimed at transforming the medicine development industry through the application of predictive analytics, machine learning, and the novel use of blockchain technology and smart contracts in clinical trials. Our mission is to bring down the cost of medicine and improve the speed to market of new medicines for the people who need them, through vastly reducing development costs for the global pharmaceutical industry. AS FEATURED ON: CLINICAL TRIALS INTELLIGENCE IS A DISTRIBUTED TECHNOLOGY PLATFORM THAT INCORPORATES PREDICTIVE DATA ANALYTICS, MACHINE LEARNING (AI), AND THE INNOVATIVE USE OF SMART CONTRACTS TO DRIVE SIGNIFICANT QUALITY AND OPERATIONAL IMPROVEMENTS IN CLINICAL TRIALS. DATA ANALYTICS With the application of powerful and insightful data analytics functionality across administrative, operational and clinical functions, stakeholders can now identify, action and resolve the potential issues detected before they negatively impact the trial. ECO-SYSTEM Clinical Trials Intelligence has created an eco-system that fosters collaboration across the entire pharmaceutical industry while addressing the privacy and security concerns of all stakeholders. CLINICAL DATA A “first of it’s kind” perpetually increasing library of clinical data analytics that facilitates the sharing of “lessons learned” across corporate boundaries without any compromise of sensitive data. WORKFLOW MANAGEMENT Advanced workflow management, including “closing the loop” functionality and a blockchain based immutable audit-trail. Pharmaceutical companies can now gain deep insight into the operational and clinical aspects of their trials without the necessity of major investment into backend technical infrastructure or data science expertise. ONE PAGE SUMMARY CLINTEX WHITEPAPER TECHNICAL PAPER KEY FEATURES * A full history of clinical trial key metrics are stored immutably on Clinical Trials Intelligence’s decentralised ledger, where they are used by Clinical Trials Intelligence’s App’s to power bespoke predictive analytics algorithms in on-going trials on the platform. * As Clinical Trials Intelligence is a fully integrated platform that provides end-to-end auditable workflow management & oversight in trials, all actions, including preventative and corrective actions (CAPA), are recorded on the Clinical Trials Intelligence blockchain on an on-going basis. * This represents the creation of a clinical eco-system that enables interoperability and safe storage of all clinical trial data views, while also addressing the privacy and security concerns of all stakeholders. CTI APPLICATIONS The CTi eco-system consists of seven separate Apps which each provide invaluable key insights and immense benefit to stakeholders such as Clinical Project Managers & Physicians, Clinical Data Managers, Pharmacovigilance staff and Site Monitors. CTI-OEM Operational Excellence Provides intuitive operational oversight of clinical trials for clinical project managers, clinical data managers and remote staff, allowing instream decision-making on what actions are required to ensure a successful project. CTI-CDV Clinical Data Visualisations Provides enhanced clinical data review through the use of data visualisations to identify issues that may impact on the trial integrity and safety of the patient e.g. data quality issues, disease exacerbation. Furthermore, CTi-CDV will facilitate flagging of these issues, and corrective actions to be recorded and monitored. CTI-PDA Predictive Analytics The CTi-PDA application will combine all operational and clinical data sources and use predictive modelling to forecast issues and events before they happen. The CTi-PDA application will reveal hidden correlations across all datasets thereby facilitating the pharmaceutical company to take pro-active action to address. CTI-RBM Risk Based Monitoring The CTi-RBM application will use current and historical data to predict specific risks, and thereby allow for tactical deployment of the pharmaceutical company’s data and site monitoring resources to take preventative action. This predictive risk based approach differs from current reactive approaches to risk and can significantly reduce site monitoring costs during a clinical trial. CTI-PRR Patient Recruitment and Retention The CTi-PRR application manages recruitment and retention of patients for clinical trials by providing a portal for patient identification and producing a series of alerts (based on predictive analytics) that flag when a patient is at risk of withdrawing from the study. CTI-SIM Site Investigators The CTi-SIM application manages the recruitment of investigators (physicians) to run clinical trials,and manages token payment compensation by the pharmaceutical company to investigators, triggered by data-driven milestones and KPIs, defined on Clinical Trials Intelligence. CTI-VMM Vendor Management CTi-VMM provides oversight on data quality and manages token payment compensation by the pharmaceutical company to the third party vendors, triggered automatically by data-driven milestones and KPIs, defined on Clinical Trials Intelligence. MEET OUR TEAM Combining the best of expertise from across the pharmaceutical, clinical, software development and data analytics spectrum. ANDRE BYRNE Chief Operating Officer READ BIO Andre has been involved in the startup world since an early age, having founded a successful media development company at the age of 22. Coming from a strongly technical background in programming, network deployment and online marketing, his interest in blockchain spans back to 2014 when he made his first investments in Bitcoin and Ethereum and fell in love with the world of decentralized technology. NEILL BARRON Director of Clinical Data Analytics READ BIO Neill leads the requirements specification, design and development of the CTi platform, ensuring it meets current and future real-world challenges for the pharmaceutical industry. He has over 20 years broad clinical development experience through a blend of senior roles in clinical data management, data analytics, technical/process improvement and site data monitoring. ETHAN DIAMANT Director of Clinical Data Services READ BIO Ethan is leading the Clinical Trial Services function, responsible for building partnerships with the pharmaceutical industry, and ensuring that evolving customer requirements are built into ClinTex’s products and services. Ethan has 19 years experience working directly in clinical trials including clinical data monitoring, study optimization and global operational excellence. MATTHEW BUCKLEY Trial Optimisation Manager READ BIO Matthew Buckley, Manager, Clinical Trial Optimisation - Matthew graduated from Leeds University with a BEng in Process and Chemical Engineering, and started working in the clinical trial space as a Data Manager in 2017. He quickly progressed to applying his engineering background to process improvement in clinical trials, having led a number of efficiency initiatives. His practical experience in this area is a welcome addition to the ClinTex team, where his skills will be used in the application of CTi to improve clinical trial efficency. BRENDAN MANNION Non Executive Director READ BIO Brendan is a highly experienced project manager and business analyst with extensive experience in financial operations, telecommunications & consumer marketing. Successful proven leadership skills, he enjoys working with people to solve problems. Brendan has had an interest in the blockchain space since 2013 and intertwines this experience with his business expertise regularly in his role as a director in ClinTex. JOHN MCCABE Head of Legal & Regulatory READ BIO John holds a BA (Hons) in Business Law and is a licenced solicitor in England, Wales and Ireland after being admitted into the Law Society of Ireland in 2013. John has been working in law for over eleven years and has a keen interest in all things blockchain. He is excited to be bringing his focus to the cryptocurrency legal and regulatory landscape. IAN HARRIGAN Senior Developer READ BIO Ian joins the team as a top level systems architect and developer with experience building solutions for NHS contractors and designing various desktop and web applications as well as complex distributed back end systems. Ian has spearheaded ClinTex' Optex development on the ICP, in association with the DFINITY foundation SHILPY GOYAL Data Analytics Developer READ BIO Shilpy holds over 10 years of experience in analytics, visualising data, data cleaning and machine learning. She has worked in various domains such as telecommunications, healthcare, and energy, and ClinTex are delighted to have her oversight and expertise and she works to build on CTi's existing data models and visualisations. SEAN COMISKEY Technology Engineering Advisor READ BIO Sean is highly motivated software engineer with experience covering the full software development life cycle, with particular specialisation in event sourcing and CQRS. He brings excellent understanding of modern software development principles, practices and paradigms to the ClinTex advisory board. WHO WE WORK WITH INTELLIMED An innovative health-tech company focusing on streamlining UK National Health Service (NHS) processes, reducing costs and improving patient care. Intellimed is part of the Serendip Digital Health quarter based at the Innovation Birmingham Campus, and will be a valuable partner for CTi Platform deployments in healthcare and clinical research settings. GLOBAL BLOCKCHAIN CONSORTIUM The GBC has been established with the mission of promoting blockchain awareness and education in the areas of fintech, disruptive tech and blockchain technologies. The GBC errand is to work in strategic collaboration with organisations and individuals that are revolutionising leading practices and wider adaptation of fintech and blockchain technologies elucidation to aid wider society. KUCOIN EXCHANGE Founded in September 2017, KuCoin has grown into one of the most popular crypto exchanges, and it currently provides a series of financial services including fiat-to-crypto, crypto-to-crypto, futures, staking, borrowing, token launch and more to its 6 million users across 207 countries and regions around the world. One out of four crypto holders worldwide is with KuCoin. TIBCO ClinTex are partnering with Tibco to utilise their Spotfire visualisation software to display the various analytics generated from the CTi data model. TIBCO Spotfire® allows users to combine data in a single analysis , and delivers AI-driven interactive visuals that will help identify the main causes of clinical trial inefficiency. SUM & SUBSTANCE Sum & Substance are a pioneer in the Trusted Digital Identity space that specialise in identity proofing, risk-based authentication, regulatory identification, and the detection and prevention of the use of stolen identities, ensuring a robust and comprehensive risk and compliance solution. BEOSIN Beosin is a well respected and experienced blockchain technology firm offering a full spectrum solution from tactical technical execution to high-level theoretical modelling, with a speciality in the auditing of smart contracts for blockchain projects. STERLING LAW Sterling Law is a modern and innovative boutique law firm with cross-domain specialisation that allows for seamless solutions to solve complex problems. CTI DEVELOPMENT ROADMAP The development of Clinical Trials Intelligence from concept to completion. 2021 Q1 | CTi-PDA Specification Development Q2 | CTi-OEM GUI Development & Testing Q3 | CTi-OEM MVP Launch Q4 | OpTex & PDA Development / Testing 2022 Q1 | CTi-PDA GUI Development & MVP Launch Optex MVP alpha target Q2 | Migration on-chain of CTi Clinical Data Statistical Summaries Q3 | Industry Pilots – Development of Visual Specs for Clinical Trial Launch Q4 | Launch CTi into active clinical trial 2018 Q1 | Ideation & Research Q2 | Concept Development Q3 | Development Sprint 1 ‘Minimum Viable Product’ Whitepaper Published Q4 | Industry Consultation on CTi Prototype Core Team Established 2019 Q1 | Development Sprint 2 ‘Enhancement’ Q3 | Proof of Concept Q4 | Strategic Partnerships Agreed Q2 | CTi Data Model Finalised 2020 Q1 | System Requirements Evaluation Private Funding Round Q2 | CTi-OEM Specification Development Q3 | CTi-OEM Prototype Development & Testing Public Token Sale Q4 | Standardisation of CTi Data model to SDTM 2021 Q1 | CTi-PDA Specification Development Q2 | CTi-OEM GUI Development & Testing Q3 | CTi-OEM MVP Launch Q4 | OpTex & PDA Development / Testing 2022 Q1 | CTi-PDA GUI Development & MVP Launch Optex MVP alpha target Q2 | Migration on-chain of CTi Clinical Data Statistical Summaries Q3 | Industry Pilots – Development of Visual Specs for Clinical Trial Launch Q4 | Launch CTi into active clinical trial 2018 Q1 | Ideation & Research Q2 | Concept Development Q3 | Development Sprint 1 ‘Minimum Viable Product’ Whitepaper Published Q4 | Industry Consultation on CTi Prototype Core Team Established 2019 Q1 | Development Sprint 2 ‘Enhancement’ Q3 | Proof of Concept Q4 | Strategic Partnerships Agreed Q2 | CTi Data Model Finalised ABOUT US ClinTex deliver intuitive blockchain-based self service analytic solutions to the pharmaceutical industry. At ClinTex, our novel Clinical Trials Intelligence solution will enhance clinical trial processes by providing tools to optimise Operational Efficiency, Clinical Data Quality and Medical Review. eClinTex t/a Clintex Limited (Estonia) Juhkentali 8, Tallinn 10132, Estonia Estonia Business Number 14991810 CONTACT US FOLLOW US Subscribe to our Newsletter to get all the latest info from ClinTex. By signing up to ClinTex emails, you acknowledge that you’re aware your personal data will be used in line with our Privacy Policy. * * * * * * TWITTER ClinTex CTiFollow ClinTex CTi@ClinTexCTi· 22h Ian Harrigan@IanHarrigan1982 #haxeui v1.5 (finally) released! With its usual write up here: https://community.haxeui.org/t/haxeui-v1-5-released Reply on Twitter 1571923486146449410Retweet on Twitter 1571923486146449410Like on Twitter 157192348614644941010Twitter 1571923486146449410 Retweet on TwitterClinTex CTi Retweeted LVL Health@HealthLvl· 16 Sep Our onboarding process at LVL Health consists of four important steps to arrange a prescription for medical cannabis. This is to ensure our treatment plan is the best option for you and your health needs. To find out more visit: http://ow.ly/TPic50KB28r Reply on Twitter 1570669017873932290Retweet on Twitter 15706690178739322902Like on Twitter 15706690178739322905Twitter 1570669017873932290 Load More... -------------------------------------------------------------------------------- Copyright © 2021 Clintex ORIGINALTEXT Bessere Übersetzung vorschlagen --------------------------------------------------------------------------------